Teva Pharmaceutical Industries, an Israel-based generic drugmaker, surprised the drug industry by requesting to join the Pharmaceutical Research and Manufacturers of America, a powerful trade ...

Wall Street analysts forecast that Teva Pharmaceutical Industries Ltd. (TEVA) will report quarterly earnings of $0.64 per share in its upcoming release, pointing to a year-over-year decline of 9.9%.

Both ANI Pharmaceuticals ANIP and Teva Pharmaceuticals TEVA operate in the pharmaceutical sector, focusing on generic and specialty medications. ANIP’s operations are split between rare disease ...

Teva Pharmaceutical is one of the world's largest generic drug companies. Teva is working to differentiate itself in generics by focusing on harder-to-produce drugs. Teva has begun manufacturing its ...